GT BIOPHARMA, INC. Treasury Stock, Common, Shares
GT BIOPHARMA, INC. (GTBP) had Treasury Stock, Common, Shares of 13.90 thousand shares as of 2022-05-13, per its 10-K filed 2025-02-21.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure
us-gaap:TreasuryStockCommonShares · last filed 2025-02-21
- 2022-05-13: Treasury Stock, Common, Shares 13.90K shares; Treasury Stock, Common, Shares as first filed 13.90M shares.
| Period end | Treasury Stock, Common, Shares | Treasury Stock, Common, Shares as first filed |
|---|---|---|
| 2022-05-13 | 13.90K shares 10-K · filed 2025-02-21 | 13.90M shares 10-K · filed 2024-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |